Related Experiment Videos
Serum plasmalogens in ischemic cerebrovascular disease
W Hoerrmann1, J Donis, E Sluga
1Bahner Stiftung für Medizin Augsburg, Deutschland.
VASA. Zeitschrift Fur Gefasskrankheiten
|January 1, 1991
Summary
Patients with ischemic cerebrovascular disease have lower plasmalogen levels in their serum compared to healthy individuals. This finding highlights plasmalogens as potential biomarkers for cerebrovascular disease diagnosis.
Area of Science:
- Biochemistry
- Neuroscience
- Lipid Metabolism
Background:
- Plasmalogens are essential glycerophospholipids found in cell membranes and lipoproteins.
- They play crucial roles in cellular structure and function.
- Alterations in plasmalogen levels are implicated in various pathological conditions.
Purpose of the Study:
- To investigate the association between plasmalogen concentrations and ischemic cerebrovascular disease.
- To determine if serum plasmalogen levels differ between patients with ischemic cerebrovascular disease and a healthy control group.
Main Methods:
- Serum samples were collected from patients diagnosed with ischemic cerebrovascular disease.
- Serum samples were also collected from a control group of healthy individuals.
- Concentrations of plasmalogens were quantified in all serum samples.
Main Results:
- Significantly lower concentrations of plasmalogens were detected in the serum of patients with ischemic cerebrovascular disease compared to the control group.
- This reduction was consistent across different plasmalogen subclasses.
Conclusions:
- Reduced serum plasmalogen levels are associated with ischemic cerebrovascular disease.
- Plasmalogens may serve as potential biomarkers for the early detection or diagnosis of ischemic cerebrovascular disease.